focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,145.00
Bid: 1,144.00
Ask: 1,149.00
Change: 11.00 (0.97%)
Spread: 5.00 (0.437%)
Open: 1,120.00
High: 1,165.00
Low: 1,120.00
Prev. Close: 1,134.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Burford Capital's Affirmative Recovery Research

8 Feb 2022 15:10

RNS Number : 0658B
Burford Capital Limited
08 February 2022
 

FOR IMMEDIATE RELEASE

 

New research on affirmative recovery programs reveals opportunity for legal departments to add value

 

Three of five GCs interviewed say their companies neglected to pursue meritorious recoveries

 

"We don't leave a dime on the table," says one GC

 

 

New York City, February 8, 2022 - Burford Capital, the leading global finance and asset management firm focused on law, today releases new independent research demonstrating that companies can unlock value in their legal departments through more systematic affirmative recovery programs.

 

As revealed by extensive one-on-one interviews with over 50 general counsel, heads of litigation and other senior legal leaders at major corporations globally, most companies have affirmative recovery programs to recover money for the business by pursuing meritorious litigation and arbitration claims when their companies are harmed. Still, many see room for improvement, with those with more systematic affirmative recovery programs showing the benefits of doing so.

 

Christopher Bogart, CEO of Burford Capital, said: "Our latest independent research is consistent with my own prior experience as a GC. Done right, affirmative recovery programs can transform in-house legal departments from cost centers to revenue generators, greatly enhancing the commercial standing of senior legal leaders in their companies.

 

"GCs benefit from hearing from their peers and from having the right tools and partners. In that spirit, we hope this new research helps companies and law firms alike realize the value of affirmative recovery programs in maximizing corporate value, and that by adding legal finance to the mix, they can greatly increase certainty around their litigation budget and cash flows."

 

Key findings from the research include:

 

· Affirmative recovery programs are expanding but are still rarely robust.

o Affirmative recovery programs are increasingly common, with two of three GCs, heads of litigation and other senior in-house lawyers interviewed saying that their companies have an affirmative recovery program. However, only a few legal leaders say their programs are robust.

§ Three of five GCs interviewed say their companies neglected to pursue meritorious recoveries.

§ Half of all GCs interviewed would exchange some upside on pending claims in exchange for removing costs and downside risk of loss.

o Senior in-house lawyers recognize that when they do pursue affirmative recoveries, new tools to increase certainty and manage costs will lead to better results.

§ Three of five GCs interviewed say quantitative financial modeling would be advantageous to affirmative litigation recoveries.

 

· Legal finance has a role to play.

o In-house lawyers whose companies use legal finance consistently say their companies have robust affirmative recovery programs that meet their needs.

o Senior in-house lawyers admit to varying levels of knowledge about legal finance, but many are hungry for more information-and many remain unsure about how it works.

o Reputation and experience top in-house lawyers' priorities when selecting legal finance partners.

 

· More systematic affirmative recovery programs benefit organizations, teams and leaders.

o Interviews with senior in-house lawyers suggest that more effective affirmative recovery programs benefit the overall enterprise, elevate legal within the organization and earn credit for legal teams for innovation and cost and risk management.

 

 

· Key quotes from the report:

 

o "Everything about what I do is about the value that the legal department generates for the company, so new creative ways of generating revenue and reducing risk is very appealing." (GC, multinational logistics company)

 

o "If you are on the plaintiff's side, you can finance your claims through a legal finance company if the business does not want to lay out the expenses, which is great. The lawyers need to understand that this option is available." (GC, capital market company)

 

o "My peers are speaking about claims as assets, which was not part of the conversation five years ago." (Head of litigation, multinational retail corporation)

 

o "We don't leave a dime on the table." (GC, capital market company)

 

o "In the last five years, we have probably recovered over $1 billion in settlements or other recoveries." (Group GC, privately held construction company)

 

 

The 2022 Affirmative Recovery Programs Report can be downloaded on Burford's website. The research report is based on 1:1 interviews conducted by phone with 52 general counsel, heads of litigation and other senior in-house lawyers with direct responsibility for their companies' commercial litigation and arbitration. The interviews were conducted between October and December of 2021 by Ari Kaplan Advisors.

 

END

 

 

Contact:

David Helfenbein

Vice President, Public Relations

dhelfenbein@burfordcapital.com, +1 212 235 6824

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, DC, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABUGDDLGGDGDI
Date   Source Headline
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares
7th Jun 20223:00 pmRNSNotification of Major Holdings
1st Jun 20223:00 pmRNSRetail Shareholder Call Registration Details
1st Jun 202210:00 amRNSSterling FX Rate for 2021 Final Dividend
26th May 202212:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSExtension of SWF Arrangement & Fund Management

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.